These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16548923)
1. Do antagonists have a role in the treatment of opioid dependence? Jaffe JH Addiction; 2006 Apr; 101(4):468-9. PubMed ID: 16548923 [No Abstract] [Full Text] [Related]
2. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism]. Poser W; Ehrenreich H Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453 [No Abstract] [Full Text] [Related]
3. Opioid antagonists: do they have a role in treatment programs? O'Brien CP; Greenstein RA; Evans B; Woody GE; Arndt R NIDA Res Monogr; 1983 Apr; 43():71-8. PubMed ID: 6410281 [No Abstract] [Full Text] [Related]
4. Can psychotherapy rescue naltrexone treatment of opioid addiction? Rounsaville BJ NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771 [No Abstract] [Full Text] [Related]
5. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Johansson BA; Berglund M; Lindgren A Addiction; 2006 Apr; 101(4):491-503. PubMed ID: 16548929 [TBL] [Abstract][Full Text] [Related]
6. Naltrexone-mediated opiate detoxification: a matter of terminology! Johnson TS; Carr M Addict Biol; 2003 Sep; 8(3):267-9. PubMed ID: 13129827 [No Abstract] [Full Text] [Related]
7. General anaesthesia is patient-friendly in opioid antagonist detoxification treatment. De Jong CJ Addiction; 2005 Nov; 100(11):1742-4. PubMed ID: 16277635 [No Abstract] [Full Text] [Related]
8. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence. Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678 [TBL] [Abstract][Full Text] [Related]
9. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness? Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538 [TBL] [Abstract][Full Text] [Related]
10. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'. Brewer C Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398 [No Abstract] [Full Text] [Related]
11. De Jong, Krabbe, Laheij & Van Cauter refuted: evidence-based non-effectiveness can hardly be patient-friendly. de Jong CJ; Laheij RJ; Krabbe PF; van Cauter Victory RM Addiction; 2005 Dec; 100(12):1884-5. PubMed ID: 16367990 [No Abstract] [Full Text] [Related]
12. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy. Degenhardt L; Gibson A; Mattick RP; Hall W Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375 [No Abstract] [Full Text] [Related]
14. Naltrexone in the treatment of opioid dependence. George S; Ekhtiari H Br J Hosp Med (Lond); 2010 Oct; 71(10):568-70. PubMed ID: 21085073 [No Abstract] [Full Text] [Related]